-transparent.png){kind=logo}
An experimental, trivalent, bovine, leptospiral vaccine, containing inactivated Leptospira interrogans serovars pomona and copenhageni and L. borgpetersenii serovar hardjo Hardjobovis, was developed. The experimental vaccine was shown to protect hamsters against virulent challenge with each of the component serovars. In a serological efficacy test in cattle, the experimental vaccine was compared for bioequivalence with a similar product, registered in New Zealand for veterinary use. The experimental vaccine induced higher titres in cattle than the latter mentioned product.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
A Palit, and
A M Alexander, and
B Slacek, and
C Taylor
March 2014,
New Zealand veterinary journal,
A Palit, and
A M Alexander, and
B Slacek, and
C Taylor
May 2018,
New Zealand veterinary journal,
A Palit, and
A M Alexander, and
B Slacek, and
C Taylor
June 1979,
New Zealand veterinary journal,
A Palit, and
A M Alexander, and
B Slacek, and
C Taylor
February 2018,
Veterinary microbiology,
A Palit, and
A M Alexander, and
B Slacek, and
C Taylor
July 1982,
American journal of veterinary research,
A Palit, and
A M Alexander, and
B Slacek, and
C Taylor
March 2021,
New Zealand veterinary journal,
A Palit, and
A M Alexander, and
B Slacek, and
C Taylor
February 1984,
Australian veterinary journal,
A Palit, and
A M Alexander, and
B Slacek, and
C Taylor
May 2012,
American journal of veterinary research,
A Palit, and
A M Alexander, and
B Slacek, and
C Taylor
September 1980,
New Zealand veterinary journal,
A Palit, and
A M Alexander, and
B Slacek, and
C Taylor
January 1979,
Australian veterinary journal,
